Document is current
Any future updates will be listed below
-
Authors
Bartsch, Rupert
- License Information
-
More Information
Article History
Accepted: 12 April 2023
First Online: 24 May 2023
Conflict of interest
: R. Bartsch: Advisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen. Lecture Honoraria: Astra-Zeneca, Daichi, Eisai, Eli-Lilly, Gilead, Gruenenthal, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen.Research Support: Daiichi, MSD, Novartis, Roche.
Free to read: This content has been made available to all.
